Mixed signals in the weekly chart shows that we are still within the bottoming process. Prices exceeded the high of the week before last week at 131.86 by making a new high at 132.06. However, last week's close at 130.69 is disappointing as it ended 19bp lower and off the highs at 132.06. This suggests that confirmation of a bottom is still required and the focus should again be on support after this weakness. Solid support in the weekly chart between 129.85 and 129.10 with the April low at 129....
Three Directors at Next Vision Stabilized Systems Ltd sold 1,245,359 shares at between 55.700ILS and 57.914ILS. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...
A director at Agile Content S.A. bought 6,000 shares at 4.300EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
A director at E-Globe S.p.A bought 15,000 shares at 1.424EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
A director at GPI S.p.A. bought 4,500 shares at 13.116EUR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Progroup reported very soft Q1/24 numbers last week, with sales down 17.1% y-o-y and EBITDA slumping 58.1% owing to lower prices. Cash flow was weak due to capex. Net leverage rose 1.2x q-o-q to 4.4x. We expect net leverage to stay elevated in the low 4x region this year, owing to EBITDA decline and cash burn. . To request full and unrestricted access to Lucror’s research and analytics platform, please visit
• Chariot has started to drill the Dartois prospect onshore Morocco. The well is targeting a different reservoir system and trapping style than the Gaufrette prospect. • The main target at Dartois is estimated to hold 12 bcf of gross prospective resources. Success would de-risk a total of 20 bcf of gross prospective resources (+8 bcf) in the Dartois area. • A rig-less well test would be run in case of success. • Our unrisked NAV for the well is £0.05 per share with a ReNAV of £0.02 per share....
In the past decade, India’s nominal GDP grew 80 per cent to $3.5 trillion by 2022, raising its global share by 1 percentage point to 3.5 per cent of global GDP. Such growth has lifted GDP per capita to $2,500 or by 64 per cent, thanks to government infrastructure spending on the likes of highways and renewable energy, effective disbursement of social welfare programs such as free food to 813 million people, corporate tax cut, and FDI incentives.The current account deficit (CAD) has narrowed, and...
A director at Biokarpet S.A sold 165,000 shares at 2.740EUR and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
A director at AKR Corporindo Tbk PT bought 24,731,300 shares at 1,619.744IDR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
TheraCryf is a clinical stage drug development company focused on commercialising its proprietary formulation of sulforaphane, SFX-01, and two novel drug candidates acquired in the recent Chronos transaction. The primary targets for SFX-01 are cancer and neurodevelopmental disorders while TheraCryf's new orexin and DAT programmes, extend the company's reach into neuropsychiatric drugs, currently a very active area for acquisitions and partnering. Potential target markets total in the billions of...
Richemont FY24 results were broadly in line with expectations but remained solid nonetheless given good sales growth at Cartier & VCA despite a tough comparison basis, and a healthy performance in Europe and the Americas. We continue to favour Richemont as growth prospects in jewellery remain p
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.